BOSTON & PARIS–(BUSINESS WIRE)–“FAID 2016” symposium will include panel presentations on Rare Diseases: Models and Opportunities as part of its February 9-10, 2016, program
Uncategorized
Senators Vent Frustration With ACA Co-op Program
(MedPage Today) — Committee chair says CMS encouraged co-ops to “cook the books”
Uncategorized
Isunakinra does not meet primary endpoint in phase 3 trial for allergic conjunctivitis
Isunakinra did not meet its primary endpoint of achieving statistically significant results in ocular itching in a phase 3 trial, according to a press release from Eleven Biotherapeutics. The phase 3 clinical trial included 258 patients with moderate t…
Uncategorized
Shire resubmits NDA for lifitegrast in response to FDA request for data
Shire has resubmitted its new drug application to the FDA for lifitegrast, an investigational treatment for dry eye disease, the company announced in a press release.Shire resubmitted the application in response to a complete response letter in which t…
Uncategorized
VIDEO: AREDS2 formulation available in single-serving packets
WAIKOLOA, Hawaii — At Hawaiian Eye, Jodi Luchs, MD, discusses the availability of OJO, a dissolvable form of the AREDS2 supplement packaged in single-serving packets.
Breakthrough discovery in the genetics of corneal dystrophies
Researchers at the UCL Institute of Ophthalmology and Moorfields Eye Hospital London, in collaboration with colleagues in the Czech Republic, have discovered a new genetic cause of corneal…